Compare DARE & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DARE | ARAY |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.4M | 39.3M |
| IPO Year | 2014 | 2006 |
| Metric | DARE | ARAY |
|---|---|---|
| Price | $1.34 | $0.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $10.00 | $3.50 |
| AVG Volume (30 Days) | 188.8K | ★ 1.2M |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,807,885.00 | N/A |
| Revenue This Year | $2,115.12 | N/A |
| Revenue Next Year | $122.62 | $4.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.16 | $0.23 |
| 52 Week High | $3.78 | $2.10 |
| Indicator | DARE | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 26.82 | 34.69 |
| Support Level | N/A | N/A |
| Resistance Level | $1.84 | $0.29 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 16.33 | 8.09 |
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.